Literature DB >> 19468973

Beta2-adrenoceptor-mediated tracheal relaxation induced by higenamine from Nandina domestica Thunberg.

Muneo Tsukiyama1, Takuro Ueki, Yoichi Yasuda, Hiroko Kikuchi, Tatsuhiro Akaishi, Hidenobu Okumura, Kazuho Abe.   

Abstract

The fruit of Nandina domestica Thunberg (ND, Berberidaceae) has been used to improve cough and breathing difficulties in Japan for many years, but very little is known about the constituent of ND responsible for this effect. We have recently reported that the crude extract from ND (NDE) inhibits histamine- and serotonin-induced contraction of isolated guinea pig trachea, and the inhibitory activity was not explained by nantenine, a well-known alkaloid isolated from ND. To explore other constituent(s) of NDE with tracheal smooth muscle relaxant activity, we fractionated NDE and assessed the pharmacological effects of the fractions using isolated guinea pig tracheal ring preparations. NDE was introduced into a polyaromatic absorbent resin column and stepwise eluted to yield five fractions, among which only the 40 % methanol fraction was active in relaxing tracheal smooth muscle precontracted with histamine. Further separation of the 40 % methanol fraction with high-performance liquid chromatography yielded multiple subfractions, one of which was remarkably active in relaxing histamine-precontracted trachea. Chemical analysis with a time-of-flight mass spectrometer and nuclear magnetic resonance spectrometer identified the constituent of the most active subfraction as higenamine, a benzyltetrahydroisoquinoline alkaloid. The potency and efficacy of the active constituent from NDE in relaxing trachea were almost equivalent to synthetic higenamine. In addition, the effect of the active constituent from NDE was competitively inhibited by the selective beta (2)-adrenoceptor antagonist ICI 118,551. These results indicate that the major constituent responsible for the effect of NDE is higenamine, which probably causes the tracheal relaxation through stimulation of beta (2) adrenoceptors. Georg Thieme Verlag KG Stuttgart-New York.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19468973     DOI: 10.1055/s-0029-1185743

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.352


  10 in total

1.  β2 -Adrenoceptor agonist profiling reveals biased signalling phenotypes for the β2 -adrenoceptor with possible implications for the treatment of asthma.

Authors:  Francesco De Pascali; Michael Ippolito; Emily Wolfe; Konstantin E Komolov; Nathan Hopfinger; Douglas Lemenze; Nicholas Kim; Roger S Armen; Steven S An; Charles P Scott; Jeffrey L Benovic
Journal:  Br J Pharmacol       Date:  2022-07-19       Impact factor: 9.473

2.  Higenamine Attenuates Doxorubicin-Induced Cardiac Remodeling and Myocyte Apoptosis by Suppressing AMPK Activation.

Authors:  Cuiliu Jin; Yu Chai; Zhimin Hu; Wencong Tian; Wang Ling; Jing Li; Meiping Wu
Journal:  Front Cell Dev Biol       Date:  2022-05-05

3.  Higenamine protects ischemia/reperfusion induced cardiac injury and myocyte apoptosis through activation of β2-AR/PI3K/AKT signaling pathway.

Authors:  Mei-ping Wu; Yi-shuai Zhang; Qian-mei Zhou; Jian Xiong; Yao-rong Dong; Chen Yan
Journal:  Pharmacol Res       Date:  2015-12-30       Impact factor: 7.658

Review 4.  Natural Antispasmodics: Source, Stereochemical Configuration, and Biological Activity.

Authors:  Edith Fabiola Martínez-Pérez; Zaida N Juárez; Luis R Hernández; Horacio Bach
Journal:  Biomed Res Int       Date:  2018-10-08       Impact factor: 3.411

5.  Therapeutic effects of higenamine combined with [6]-gingerol on chronic heart failure induced by doxorubicin via ameliorating mitochondrial function.

Authors:  Jianxia Wen; Lu Zhang; Jian Wang; Jiabo Wang; Lifu Wang; Ruilin Wang; Ruisheng Li; Honghong Liu; Shizhang Wei; Haotian Li; Wenjun Zou; Yanling Zhao
Journal:  J Cell Mol Med       Date:  2020-02-19       Impact factor: 5.310

Review 6.  Role of Higenamine in Heart Diseases: A Mini-Review.

Authors:  Jianxia Wen; Mingjie Li; Wenwen Zhang; Haoyu Wang; Yan Bai; Junjie Hao; Chuan Liu; Ke Deng; Yanling Zhao
Journal:  Front Pharmacol       Date:  2022-01-10       Impact factor: 5.810

Review 7.  Higenamine in Plants as a Source of Unintentional Doping.

Authors:  Vanya Rangelov Kozhuharov; Kalin Ivanov; Stanislava Ivanova
Journal:  Plants (Basel)       Date:  2022-01-27

Review 8.  Pharmacological effects of higenamine based on signalling pathways and mechanism of action.

Authors:  De-Ta Chen; Wu Rao; Xue Shen; Lin Chen; Zi-Jian Wan; Xiao-Ping Sheng; Tian-You Fan
Journal:  Front Pharmacol       Date:  2022-09-15       Impact factor: 5.988

9.  Biocatalytic production of tetrahydroisoquinolines.

Authors:  Bettina M Ruff; S Bräse; Sarah E O'Connor
Journal:  Tetrahedron Lett       Date:  2012-02-29       Impact factor: 2.032

10.  Synthesis and Detailed Examination of Spectral Properties of (S) and (R)-Higenamine 4'-O-β-d-Glucoside and HPLC Analytical Conditions to Distinguish the Diastereomers.

Authors:  Eisuke Kato; Ryohei Iwata; Jun Kawabata
Journal:  Molecules       Date:  2017-08-31       Impact factor: 4.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.